Granulocyte function was studied in 9 patients with untreated, Ph1-positive chronic myelocytic leukemia (CML). The nitroblue tetrazolium reduction by stimulated granulocytes was impaired in all patients; 4 patients also had diminished phagocytosis and 2 others defective Chemotaxis. In spite of this variety of polymorphonuclear (PMN) functional impairments, there is little evidence of increased susceptibility to infections in CML patients. This suggests that CML-PMN leucocytes (PMNs) may be successfully used for transfusion into neutropenic recipients, as previously reported. To evaluate the effects of irradiation and liquid storage on CML-PMNs, 5 of our patients were subjected to leukapheresis by continuous-flow centrifugation in the Aminco Celltrifuge, and granulocyte functional capacities were also evaluated on the cell-rich plasma immediately after collection and after short-term storage at 4°C with or without irradiation (1500 rads). As evaluated by in vitro studies, granulocytes maintained, even after irradiation, functional activities similar to those found immediately after collection up to 24 h of storage at 4°C and presented a moderate loss of function after 48 h. Chemotaxis appeared to be the most sensitive detector for cellular damage of stored leucocytes, irradiated and non-irradiated, so that it might be used for assessment of leucocyte function before transfusion.
Get full access to this article
View all access options for this article.
References
1.
AlaviJ.B., RootR.K., DjerassiI., EvansA.E., GluckmanS.J., MacGregorR.R., GuerryD., SchreiberA.D., ShawJ.M., KochP., CooperR.A.: A randomized clinical trial of granulocyte transfusions for infection in acute leukemia.New Engl. J. Med.,296: 706–711, 1977.
2.
AllisonA.C.: Mechanism of movement and maintenance of polarity in leucocytes. pp. 191–217. In: Chemotaxis: Its Biology and Biochemistry.SorkinE. (ed.). Karger, Basel, 1974.
AuneJ.M., WadeN.J.: Physiology of aging leukocytes. I. Phagocytosis and transformation.Proc. Soc. Exp. Biol. Med.,134: 421–426, 1970.
5.
BanerjeeT.K., SennH., HollandJ.F.: Comparative studies on localized leucocyte mobilization in patients with chronic myelocytic leukemia.Cancer,29: 637–644, 1972.
6.
BrandtL.: Adhesiveness to glass and phagocytic activity of neutrophilic leukocytes in myeloproliferative disease.Scand. J. Haemat.,2: 126–136, 1965.
7.
BusselA.: Conditions d'efficacité thérapeutique des transfusions de leucocytes. Nouv. Rev. Franç.Hémat.,16: 147–148, 1976.
8.
BusselA., BenbunanM.J., GrangeM.J., BoironM., BernardJ.: Comparison of clinical results induced by irradiated and non-irradiated chronic myelocytic leukemia cell transfusions and the relationship to in vitro studies. pp. 395–401. In: Leucocytes: Separation, Collection and Transfusion.GoldmanJ.M., LowenthalR.M. (eds.). Academic Press, London, 1975.
9.
CarruthersB.M.: Leukocyte motility. II. Effect of absence of glucose in medium; effect of presence of deoxyglucose, dinitrophenol, puromycin, actinomycin D acid and trypsin on the response to chemostactic substance; effect of segregation of cells from chemostactic substance.Can. J. Physiol. Pharmacol.,45: 269–280, 1967.
10.
ChrétienJ.H., GaragusiV.F.: Corticosteroid effect on phagocytosis and NBT reduction by human polymorphonuclear neutrophils.J. Ret. Endoth. Soc.,11: 358–367, 1972.
11.
CramerE., AuclairC., HakimJ., FeliuE., BoucherotJ., TroubeH., BernardJ.F., BergogneE., BoivinP.: Metabolic activity of phagocytosing granulocytes in chronic granulocytic leukemia: Ultrastructural observation of a degranulation defect.Blood,50: 93–106, 1977.
12.
CrowleyJ.P., ValeriC.R.: Recovery and function of granulocytes stored in plasma at 4°C for one week.Transfusion,14: 574–580, 1974.
13.
CurtisJ.E., HasselbackR., BergsagelD.E.: Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia.Can. Med. Assoc. J.,117: 341–343, 1977.
14.
El-MaalemH., FletcherJ.: Defective neutrophil function in chronic granulocytic leukaemia.Br. J. Haemat.,34: 95–103, 1976.
15.
FialkowP.J., JacobsonR.J., PapayannopoulouT.: Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.Am. J. Med.,63: 125–130, 1977.
GrawR.G., HerzigG.P., PerryS., HendersonE.S.: Normal granulocyte transfusion therapy: Treatment of septicemia due to gram-negative bacteria.New Engl. J. Med.,287: 367–371, 1972.
19.
GrawR.G., StoutE.G., HerzigR.H., HerzigG.P.: Granulocyte transfusion therapy for life-threatening bacteriemia: Results of transfusion trials at the National Cancer Institute. pp. 267–280. In: The Granulocyte: Function and Clinical Utilization.GreenwaltT.J., JamiesonG.A. (eds.). Alan R. Liss, Inc., New York, 1977.
20.
HakimJ., CramerE., AuclairC., GougerotM., FeliuE., BoivinP.: Acquired functional defect of human blood polymorphonuclears. pp. 375–383. In: Movement, Metabolism and Bactericidal Mechanisms of Phagocytes.RossiF., PatriarcaP.L., RomeoD. (eds.), Piccin, Padova, 1977.
21.
HigbyD.J., BurnettD., RuppertK., HendersonE.S., CohenE.: Granulocyte transfusions: Experience at Roswell Park Memorial Institute. pp. 293–304. In: The Granulocyte: Function and Clinical Utilization.GreenwaltT.J., JamiesonG.A. (eds.). Alan R. Liss, Inc., New York, 1977.
22.
HigbyD.J., YatesJ.W., HendersonE.S., HollandJ.F.: Filtration leukapheresis for granulocyte transfusion therapy: Clinical and laboratory studies.New Engl. J. Med.,292: 761–766, 1975.
23.
HolleyT.R., Van EppsD.E., HarveyR.L., AndersonR.E., WilliamsR.C.: Effect of high doses of radiation on human neutrophil chemotaxis, phagocytosis and morphology.Am. J. Path.,75: 61–72, 1974.
24.
KalinskeR.W., HoeprichP.D.: Engulfment and bactericidal capabilities of peripheral blood leukocytes in chronic leukemias.Cancer Res.,23: 1094–1102, 1969.
25.
KaplowL.S.: Cytochemistry of leucocyte alkaline phosphatase. Use of complex naphthol as phosphates in azo dye-coupling technics.Am. J. Clin. Path.,39: 439–442, 1963.
26.
KellerH.U., HessM.W., CottierH.: Physiology of Chemotaxis and random motility.Sem. Hematol.,12: 47–57, 1975.
27.
LichtmanM.A., ChamberlainJ.K., WeedR.I., PincusA., SantilloP.A.: The regulation of the release of granulocytes from normal marrow. pp. 53–75. In: The Granulocyte: Function and Clinical Utilization.GreenwaltT.J., JamiesonG.A. (eds.). Alan R. Liss, Inc., New York, 1977.
28.
LowenthalR.M., GrossmanL., GoldmanJ.M., StorringR.A., BuskardN.A., ParkD.S., MurphyB.C., SpiersA.S.D., GaltonD.A.G.: Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anemia.Lancet,1: 353–358, 1975.
29.
MacGregorR.R., SpagnuoloP.J., LentnekA.L.: Inhibition of granulocyte adherence by ethanol, prednisone and aspirin measured with a new assay system.N. Engl. J. Med.,271: 642–645, 1974.
30.
McCredieK.B., HesterJ.P., VallejosC.S., FreireichE.J.: Clinical results of granulocyte transfusions using normal donors. pp. 287–291. In: Leucocytes: Separation, Collection and Transfusion.GoldmanJ.M., LowenthalR.M. (eds.). Academic Press, London, 1975.
31.
McCulloughJ.: Liquid preservation of granulocytes for transfusion. pp. 185–191. In: The Granulocyte: Function and Clinical Utilization.Alan R. Liss, Inc., New York, 1977.
32.
McCulloughJ., CarterS.J., QuieP.G.: Effects of anticoagulants and storage on granulocyte function in bank blood.Blood,43: 207–217, 1974.
33.
MillerM.E.: Chemotaxis and random mobility. Clinical and biological differentiation. pp. 338–349. In: Chemotaxis: Its Biology and Biochemistry.SorkinE. (ed.). Karger, Basel, 1974.
34.
MorseE.E., FriereichE.J., CarboneP.P., BronsonW., FreiE.J.: The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia.Transfusion,6: 183–192, 1966.
35.
OdebergH., OlofssonT., OlssonI.: Granulocyte function in chronic granulocytic leukemia. I. Bactericidal and metabolic capabilities during phagocytosis in isolated gronulocytes.Br. J. Haemat.,29: 427–441, 1975.
36.
OlofssonT., OdebergH., OlssonI.: Granulocyte function in chronic granulocytic leukemia. II. Bactericidal capacity, phagocytic rate, oxygen consumption, and granule protein composition in isolated granulocytes.Blood,48: 581–593, 1976.
37.
van OssC.J., GillmanC.F., NeumannA.W.: Phagocytic engulfment and cell adhesiveness as cellular surface phenomena. pp. 1–6. Marcel Dekker Inc., New York, 1976.
38.
ParkB.H., FikrigS.M., SmithwickE.M.: Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic aid.Lancet,2: 532–534, 1968.
39.
ParkB.H., GoodR.A.: NBT test stimulated.Lancet,2: 616, 1970.
40.
PatroneF., DallegriF., BremaF., SacchettiC.: Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugation (CFC).Exp. Hemat., 1979 (in press).
41.
PennyR., GaltonD.A.G.: Studies on neutrophil function.II. Pathological aspects. Br. J. Haemat.,12: 633–645, 1966.
42.
PinkertonP.H., RobinsonJ.B.: Granulocyte function in untreated acute and chronic granulocytic leukemia.Acta Haemat.,56: 65–72, 1976.
43.
RosnerF., ValmontI., KozinnP.J., CarolineL.: Leukocyte function in patients with leukemia.Cancer,25: 835–842, 1970.
44.
RusselJ.A., PowlesR.L.: A practical guide to granulocyte transfusion therapy.J. Clin. Path.,29: 369–379, 1976.
45.
SbarraA.J., ShirleyW., SelvarayR.J., McRipleyR.J., RosenbaumE.: The role of the phagocyte in host-parasite interactions. III. The phagocytic capabilities of leucocytes from myeloproliferative and other neoplastic disorders.Cancer Res.,25: 1199–1206, 1965.
46.
StosselT.P.: The mechanism of leukocyte locomotion. pp. 143–157. In: Leukocyte Chemotaxis: Methods, Physiology and Clinical Implications.GallinJ.I., QuieP.G. (eds.). Raven Press, New York, 1978.
47.
TanC.V., RosnerF., FeldmanF.: Nitroblue tetrazolium dye reduction in various hematologic disorders. N.Y.State J. Med.,73: 952–956, 1973.
48.
UndritzE.: Planches d'Hématologie. p. 35. Sandoz, 1972.
49.
WadeP.H., SkrabutE.M., VinciguerraL., ValeriC.R.: In vitro function of granulocytes isolated from blood of normal volunteers using continuous-flow centrifugation in the IBM-Aminco Celltrifuge and adhesion-filtration leukapheresis using nylon fiber.Transfusion,17: 136–140, 1977.
50.
WhittakerJ.A., KhurshidM., HugherH.R.: Neutrophil function in chronic granulocytic leukemia before and after Busulphan treatment.Br. J. Haemat.,28: 541–549, 1974.
51.
WilkinsonP.C.: Chemotaxis and Inflammation.Churchill Livingstone, Edinburg-London, 1974.
52.
ZigmondS.H., HirschJ.G.: Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of cell-directed chemotactic factor.J. Exp. Med.,137: 387–410, 1973.
